Nasus Pharma announced that Eyal Rubin will depart as chief financial officer in September. Further details regarding his replacement or the transition were not immediately available.
Nasus Pharma CFO Eyal Rubin to leave in September
The chief financial officer of Nasus Pharma will step down at the end of September.
PA
Priya Anand · Equities & Earnings Desk · 19 Aug 2026 · 12:36 · 1 min read
This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
PA
Written by
Priya Anand
Equities & Earnings Desk
Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
More from Priya Anand →
